Federal research funding wobble
Scientists are seeing delays and cuts in federal biomedical funding, creating uncertainty for labs and early-career researchers. Reports point to paused grants and budget pressure even as some senators rejected a White House proposal to cap NIH institutional overheads, and one University of Iowa professor still secured nearly $3 million to expand antibody research. (vnews.com) (rollcall.com) (now.uiowa.edu)
Federal biomedical research money is arriving more slowly and less predictably in 2026, leaving many university labs waiting on grants and trimming plans. (aamc.org) By March 20, the National Institutes of Health had obligated $5.8 billion in extramural funding, or about 15% of the roughly $38 billion it is expected to spend this fiscal year. The Association of American Medical Colleges said that total was 34% below the same point in fiscal 2024. (aamc.org) The slowdown shows up in award counts too. Grant Witness data cited by GenomeWeb showed 13,091 National Institutes of Health awards as of April 5, down 17% from 15,686 a year earlier and 33% from 19,522 in 2024. (genomeweb.com) New grants are lagging even further behind renewals. As of April 5, the agency had made 1,853 new and competitive renewal awards, down 44% from 3,320 in 2025 and 62% from 4,816 in 2024. (genomeweb.com) For a lab, a federal grant pays for salaries, supplies, animals, data collection, and years of step-by-step experiments. When notices of award arrive late, universities delay hiring, researchers slow purchases, and early-career scientists can miss the next application cycle. (idsociety.org) (vtdigger.org) Part of the bottleneck traces to the longest full federal shutdown in United States history, which ran from October 1, 2025, to November 12, 2025, at the start of fiscal 2026. GenomeWeb reported that researchers and consultants still see that disruption in the grant pipeline months later. (genomeweb.com) Research groups also say staffing cuts and policy changes inside the agency have slowed reviews and awards. The Infectious Diseases Society of America said recent reductions in staff capacity have delayed grant guidance, notices of award, and some application processing. (idsociety.org) At the same time, the White House is again pressing to limit how much the National Institutes of Health reimburses universities for indirect costs such as utilities and building maintenance. President Donald Trump’s fiscal 2027 budget proposes a 15% cap, after Congress rejected the same idea in the fiscal 2026 cycle and federal courts blocked agencies from imposing it. (rollcall.com) Top Senate appropriators from both parties are already pushing back. Senator Susan Collins of Maine and Senator Shelley Moore Capito of West Virginia said they do not support a one-size-fits-all cap and instead pointed to a research-backed alternative called the Financial Accountability In Research model. (rollcall.com) The picture is not all cuts. The University of Iowa said one of its faculty members won nearly $3 million from the National Institutes of Health to keep supplying antibodies through the Developmental Studies Hybridoma Bank, a long-running resource that sends research tools to scientists worldwide. (now.uiowa.edu) That mix of delayed awards, budget fights, and a few fresh grants is what labs are navigating in April 2026. Congress now heads toward the fiscal 2027 spending process with the National Institutes of Health pipeline still running behind. (rollcall.com) (aamc.org)
